• 농업과학연구
• /
• 제35권2호
• /
• pp.167-176
• /
• 2008

Supplementation of serum and estrogen in in vitro maturation(IVM) medium was shown to improve embryo development and quality in several species. This study investigates the effect of ovarian estrus stage on canine oocyte quality and supplementation of medium with canine serum or estrogen on IVM of canine oocytes. As results, in experimental 1, IVM oocytes collected from follicular stage ovaries to MII stages($10.2{\pm}1.5%$) was higher (p<0.05) with 10% canine estrus stage serum than control($1.3{\pm}1.6%$), anoestrus stage serum($4.0{\pm}1.6%$), luteal stage serum($2.7{\pm}1.7%$) and 10% FBS($1.3{\pm}1.6$). In experimental 2, 10% canine estrus stage serum supplementation has highest maturation rate to MII stages($10.0{\pm}1.8%$) and there were significant differences(P<0.05) with another treatment in follicular stages group. In order to investigate the synergic effect of estrous serum and estrogen supplementation, different estrous stage groups of oocytes were cultured with 2 ug/ml estrogen plus various concentrations of different reproductive stage serum and FBS(experimental 3). As results, the rate of maturation to metaphase II(MII) stage was significantly higher(p<0.05) in oocytes from the follicular stage supplemented with estrogen and 10% canine estrus stage serum(11.5%) compared to the other groups(6.0 - 8.8%). The present study was demonstrated that canine serum and the estrus cycle of the bitch affect the meiotic competence of oocytes. Hormonal influences within the follicle may be one of the factors responsible for the greater proportion of maturation of oocyte to MII from bitches at the follicular phase.

• Clinical and Experimental Reproductive Medicine
• /
• 제21권3호
• /
• pp.241-245
• /
• 1994

Despite increasing success rate of IVF, poor response to ovarian stimulation remains a problem. So, attempts to improve ovarian responses, for example, by using combined gonadotropin-releasing hormone analogue(GnRH-a) and human menopausal gonadotropin(hMG) have shown limited success. It is reported that response of granulosa cells in vitro to FSH is stimulated by co-incubation with IGF-l, and IGF-l production can be increased by growth hormone. This suggest that combination regimen of G.H. and hMG may augment follicle recruitment. In fifteen patients who had previous history of poor ovarian response to gonadotropin stimulation after pituitary suppression with mid -luteal GnRH-a, the effectiveness of cotreatment with G.H. in IVF program was evaluated using a combination regimen of G.R. and hMG at Korea University Hospital IVF Clinic. Ovarian responses to gonadotropin stimulation in control and GH-treated cycles assessed by total dose and duration of hMG treatment, follicular development and peak $E_2$ level, number of eggs retrieved, and fertilization rates were also assessed. In each group, serum and follicular fluid IGF-1 concentrations on day of egg collection were measured by RIA after acidification and extraction by reveresed phase chromatography. Patients receiving G.H. required fewer days and ampules of gonadotropins, developed more oocytes, and more embryos transferred. But, the differences were not statistically significant, except the duration of hMG treatment. Our data showed a significantly higher concentration of IGF-l in the serum, not in the follicular fluid, of patients treated with G.H. compared with control group. These data suggest that growth hormone treatment does not improve the ovarian response in women with limited ovarian reserve to gonadotropin stimulation for IVF.

• 농업과학연구
• /
• 제11권2호
• /
• pp.233-243
• /
• 1984

본(本) 연구(硏究)는 Landrace순종(純種)의 미경산돈(未經산豚) 6두(頭)를 가지고 발정주기(發情週期) 및 임신기간(妊娠期間)동안의 혈청중(血淸中) 성(性) hormone수준(水準)의 변화(變化)를 구명(究明)하기 위하여 실시(實施)하였으며, 이정맥(耳靜脈)에서 혈액(血液)을 채취(採取)하여 혈청(血情)을 분리(分離)한 다음, 이를 시료(試料)로 하여 LH, FSH, prolactin, progesterone, $estradiol-17{\beta}$ 및 cortisol을 radioimmunoassay 방법(方法)으로 분석(分析)하였는바, 그 결과(結果)를 요약(要約)하면 다음과 같다. 1. Landrace순종(純種) 미경산돈(未經産豚)의 성성숙도달일령(性成熟到達日齡)은 179.5일(日), 성성숙도달체중(性成熟到達體重)은 88.2kg, 발정주기(發情週期) 21.3일(日), 임신기간(妊娠期間)은 114일(日)이었고, 복당산자수(腹當산仔數)는 9.5두(頭)였다. 2. 발정주기중(發情週期中)의 LH농도(濃度)는 1.56mIU/ml 이하(以下), prolactin 농도(濃度)는 2.4ng/ml 이하(以下)로 분석한계수준이하(分析限界水準以下)였다. FSH농도(濃度)는 발정열시후(發情閱始後) 6일(日)부터 15일(日)까지 1.50~2.20 mIU/ml 범위(範圍)였으며, 발정시(發情時)와 발정전후(發情前後) 3일(日)에는 1.25 mIU/ml 이하(以下)였다. 3. 발정주기중(發情週期中)의 progesterone 농도(濃度)는 발정일(發情日)에 1.90ng/ml를 나타냈으나, 발정열시후(發情閱始後) 3일(日)에 13.10ng/ml 증가(增加)하였고 9일(日)에 최고수준(最高水準)에 도달(到達)하였다. $Estradiol-17{\beta}$농도(濃度)는 발정일(發情日)과 발정개시후(發情開始後) 18일(日)에 27.2pg/ml을 나타냈고, 그밖의 기간(期間)에서는 27.2pg/ml 이하(以下)였다. Cortisol 농도(濃度)는 발정일(發情日)에 최고수준(最高水準)에 도달(到達)했으며, 황체기(黃體期)동안에는 24.65~28.57ng/ml 범위(範圍)에 있었다. 4. 임신기간중(姙娠期間中)의 LH농도(濃度)는 3.10~4.37 mIU/ml, FSH농도(濃度)는 1.30~1.80 mIU/ml, 그리고 prolactin 농도(濃度)는 2.60~6.70ng/ml의 범위(範圍)를 나타냈다. 5. Progesterone 농도(濃度)는 전임신기간(全姙娠期間)에 38.90~16.85ng/ml 범위(範圍)에 있었으나 분만시(分娩時)에는 1.96ng/ml로 급격(急激)히 감소(減少)하였다. $Estradiol-17{\beta}$의 농도(濃度)는 임신후(姙娠後) 15일(日)에 27.2pg/ml을 나타냈으며, 그후 계속(繼續) 증가(增加)하여 분만시(分娩時)는 620.17pg/ml을 나타냈다. Cortisol 농도(濃度)는 전임신기간(全姙娠期間)에 걸쳐 13.58~24.35ng/ml의 범위(範圍)를 나타냈다.

• Reproductive and Developmental Biology
• /
• 제30권3호
• /
• pp.213-218
• /
• 2006

본 연구는 젖소의 분만 후 난소 주기 재개의 이상이 번식 성적에 미치는 영향을 구명하기 위해 수행하였다. 정상적인 난소 주기가 진행이 되면 배란된 날에 난소 주기가 재개된 것으로 간주하였다. 공시우의 58.8%(l14/194)가 정상적인 난소 주기의 재개를 하였고 41.2%의 소에서 난소 주기의 재개가 지연되었다. 배란 후 황체기가 20일 이상 유지되는 난소 주기의 재개지연 I형(17.5%)과 분만 후 40일 이전에 첫 배란이 나타나지 않는 난소 주기의 재개지연 II형(22.7%)이 난소 주기 재개 지연의 일반적인 형태였다. 정상적인 난소 주기를 가진 개체와 비교해 보면, 황체기가 연장된 소들의 분만 후 100일 이내의 인공수정 공시율, 수태율과 임신율은 더 낮고(각각 84.2 대 40.0%; p<0.01, 24.0 대 21.4%, 20.2 대 11.1%) 분만 후 첫 수정 일수와 공태 일수가 더 길다(각각 $64.7{\pm}2.79$ 대 $105.7{\pm}7.48$일; p<0.01, $105.1{\pm}7.16$ 대 $133.7{\pm}11.17$일). 정상우와 무배란우를 비교해 보면, 100일 이내의 수태율과 임신율이 낮고(각각 24.0대 20.0%, 20.2 대 16.3%) 분만 후 첫 수정 일수과 공태 일수가 더 길다(각각 $64.6{\pm}2.79$ 대 $72.6{\pm}4.45$일, $105.1{\pm}7.16$ 대 $120.8{\pm}12.33$일). 결론적으로 젖소의 분만 후 비정상적인 난소 주기는 인공수정 공시율, 임신율, 첫 수정 일수와 공태 기간을 포함하는 번식 성적의 저하를 유발시킨다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제17권4호
• /
• pp.460-466
• /
• 2004

This study was undertaken with the aim to establish a reliable radioimmunoassay (RIA) system for urinary pregnanediol glucuronide (PdG) and to employ it for monitoring the reproductive status of dairy cows. Urine and blood samples were collected from the Holstein cows both pregnant and non-pregnant. The samples were then investigated for evaluating the relationship between progesterone ($P_{4}$) in blood and PdG in urine adjusted with or without urinary creatinine basis. Biweekly urine collection was employed for three cows in estrous and those artificially inseminated, while urine from pregnant cows was collected on a monthly basis. P_{4}$ and PdG levels were measured by enzymeimmunoassay (EIA) and RIA techniques, respectively. Our results indicated the sensitivity of PdG for RIA being 35 pg/tube and the recovery rate of 100%. Urinary creatinine concentrations also fluctuated within a day, but change at midday was not noteworthy. Regardless of the time of urination the change in concentrations of PdG was relatively smaller and did not vary significantly. The urinary PdG concentration showed periodic changes as that with serum P_{4}$ levels during the cow's estrus cycle. The correlation coefficient rose when creatinine level in urine was adjusted but the change was also not significant. The concentrations of PdG during the luteal phase were detected between 8.2 and 17.4 ng/ml, three to five times higher than that in the follicular phase. The concentration of PdG from pregnant cows (21 days after conception) was three to four times higher than in the nonpregnant cows. Our finding suggests that the determination of urinary PdG could be reliably employed for early pregnancy detection. The urinary PdG level continued to raise until 30 days pre-partum while the concentration reached its peak at 30 ng/ml, after which it started to fall 18 to 30 days before parturition and finally fell to its nadir value one week after parturition. As the correlation coefficient between the urinary PdG and serum P_{4}$ was higher than that corrected by urinary creatinine it can be suggested that the adjustment is not needed. The concentrations of urinary PdG could be maintained stably for 2 days in urine samples stored at room temperature and extended to 8 days when the samples were pretreated by boiling for 30 minutes. In conclusion urinary PdG concentration even without the need for creatinine basis adjustment can be used directly for monitoring the reproductive status of dairy cows.

• 한국운동역학회지
• /
• 제19권1호
• /
• pp.99-106
• /
• 2009

연구의 목적은 여성 호르몬 변화가 무릎의 느슨함에 영향을 미치는지에 관한 연구가 실시되었다. 23명의 여성피험자들이 본 실험에 참여하였다. 각 피험자의 호르몬 주기 중에 세 차례에 걸쳐 에스트라디올과 프로제스트론을 혈액들 통해서 산출되었다. 첫 번째 측정은 호르몬주기의 초기 중 3일과 7일 사이에, 두 번째 측정은 배란측정기를 통해서 에스트로겐의 최고치 측정 후 24시간에서 48시간 후인 배란기에 실시되었다. 세 번째 측정은 28일의 평균 호르몬주기를 기준으로 두 번째 측정 후 약 7일이 지난 후에 실시되었다. 무릎 관절의 느슨함 정도가 측정기기(KT-2000)를 통해서 호르몬 수치와 함께 동시에 측정되었다. 다중회귀분석을 통해서 호르몬의 수치와 무릎의 느슨함 정도가 각 시기별로 비교되었다. 호르몬의 수치들은 세 차례의 시기 간에 차이가 있었다. 무릎의 느슨함은 각각 호르몬 배란기 동안에 증가를 나타내었다. 다중 회귀방정식을 통해서 20lb좌 30lb의 부하 수준에서 77.9%에서 80.9%4의 예측수준을 나타내었고 두 호르몬 간에 관계가 관절의 느슨함에 상호 상쇄적인 영향을 미치는 것으로 나타났다. 따라서 호르몬의 수치가 무릎의 느슨함을 적절하게 예측할 수 있었다. 이러한 결과를 통해서 개인의 호르몬 수치의 프로파일을 통해서 관절의 느슨함과 같은 관절의 특성을 이해하고 이를 통해서 스포츠 상황에서의 관절상해에 관한 유용한 정보를 제공할 수 있겠다.

• 정신신체의학
• /
• 제5권1호
• /
• pp.52-62
• /
• 1997

This study was designed to determine the frequency of premenstrual dysphoric disorder in gynecological outpatients, and also attempted to compare premenstrual change characteristics, functional impairment due to premenstrual changes and frequency of risk factors reported by women with confirmed premenstrual changes$(PMC^+)$(n=17) and those without confirmed premenstrual changes$(PMC^-)$(n=23). Forty gynecological outpatients who complained of premenstrual discomforts were asked to complete questionnaires on menstrual history, obstetric-gynecological history, and premenstrual change and functional impairment. The women were also asked to complete a daily rating form based on DSM-IV diagnostic criteria for one menstrual cycle. Absolute severity method, effect size method and percent change method were used to assess changes between follicular phase and luteal phase. The results of the study were as follows: 1) The frequency of premenstrual dysphoric disorder according to each of the three methods was 5% for the absolute severity method, 15% for the effect size method, and 27.5% for the percent change method. 2) The frequently reported symptoms were as follow: physical symptoms(64.7%) : lethargy, easy fatigability, or marked lack of energy(41.2%) : decreased interest in usual activities(29.4%) ; and marked affective lability(23.5%). 3) There were no significant differences in onset ages of premenstrual changes, regularities of premenstrual changes and changes of severity and duration of premenstrual symptoms over time between women with and without confirmed premenstrual changes. However, women with confirmed premenstrual changes reported both physical and emotional symptoms as earliest symptoms most frequently, while women without confirmed premenstrual changes reported only physical symptoms most frequently. 4) functional impairment was significantly higher in women with confirmed premenstrual changes than those without confirmed premenstrual changes, but impairment was not severe. 5) No differences were found between women with and without confirmed premenstrual changes in risk factors including demographic data, menstrual and obstetric and gynecological history. These results suggest that the prevalence of premenstrual dysphoric disorder varies with scoring methods. The women with confirmed premenstrual changes reported physical symptoms most frequently(64.7%). functional impairment was significantly higher in women with confirmed premenstrual changes, but impairment was not severe.

• 수면정신생리
• /
• 제6권1호
• /
• pp.46-51
• /
• 1999

목 적 : 광치료는 계절성 기분장애, 약간의 비계절성 주요 우울장애 및 월경전우울증 등의 치료에 이용되고 있다. 저자들은 일중주기리듬의 장애가 병인론으로 제시되고 있는 월경전 불쾌기분 장애에 대한 광치료 효과를 평가하기 위하여 광치료의 임상시도를 하였다. 방 법 : DSM-IV의 월경전 불쾌기분장애 진단기준에 충족되는 4명의 환자에서 광박스(light box,Apolo bright lite III)를 이용한 저녁 광치료(6:30-8:00pm) 시도하였다. 결 과 : 연구대상은 광치료 후, 그 정도에는 차이가 있으나, 월경전기 증상과 더불어 우울기분과 불안이 감소하는 변화를 보였다. 본 연구는 임상시도로 연구대상이 적고, 위약 효과의 통제가 없으며, 증상 평가 방법에 있어 어려움 등 한계가 있으나, 이러한 변화는 특히 비정형 우울증상이 있는 환자에서 두드러졌으며, 신체증상보다는 심리증상에 보다 효과적인 결과를 보였다. 결 론 : 광치료는 월경전불쾌기분 장애 환자의 약물학적 치료에 대안적 방법으로 볼 수 있겠다. 향후 보다 많은 수의 환자를 대상으로, 위약대조 교차연구(아침, 저녁 광치료)가 필요할 것으로 사료된다.

• Animal Bioscience
• /
• 제35권12호
• /
• pp.1850-1859
• /
• 2022

Objective: The quantitative reverse transcription polymerase chain reaction (qPCR) is the most accurate and reliable technique for analysis of gene expression. Endogenous reference genes (RGs) have been used to normalize qPCR data, although their expression may vary in different tissues and experimental conditions. Verification of the stability of RGs in selected samples is a prerequisite for reliable results. Therefore, we attempted to identify the most stable RGs in the hypothalamic-pituitary-gonadal (HPG) axis in sows. Methods: The cycle threshold values of nine commonly used RGs (18S, HPRT1, GAPDH, RPL4, PPIA, B2M, YWHAZ, ACTB, and SDHA) from HPG axis-related tissues in the domestic sows in the different stages of estrus cycle were analyzed using two RG-finding programs, geNorm and Normfinder, to rank the stability of the pool of RGs. In addition, the effect of the most and least stable RGs was examined by normalization of the target gene, gonadotropin-releasing hormone (GnRH), in the hypothalamus. Results: PPIA, HPRT1, and YWHAZ were the most stable RGs in the HPG axis-related tissues in sows regardless of the stages of estrus cycle. In contrast, traditional RGs, including 18S and ACTB, were found to be the least stable under these experimental conditions. In particular, in the normalization of GnRH expression in the hypothalamus against several stable RGs, PPIA, HPRT1, and YWHAZ, could generate significant (p<0.05) elevation of GnRH in the preovulatory phase compared to the luteal phase, but the traditional RGs with the least stability (18S and ACTB) did not show a significant difference between groups. Conclusion: These results indicate the importance of verifying RG stability prior to commencing research and may contribute to experimental design in the field of animal reproductive physiology as reference data.

• Clinical and Experimental Reproductive Medicine
• /
• 제12권1호
• /
• pp.47-70
• /
• 1985

This study was presented of the 1,872 cases of infertile couples who visited and examined at the sterility clinic of Department of Obstetrics & Gynecology, Seoul National University Hospital from Sept., 1980 to Dec., 1983. Age, duration of infertility, past medical history, and other general factors were analyzed, and the factors responsible for infertility were classified and discussed. Mode of treatment, outcome of pregnancy, pregnancy rate responsible for each factor were also presented. The results were as follows: 1) The infertility was primary in 1,128, or 60.3% and secondary in 744, or 39.7%. 2) The age between 26 and 30 years of age comprised about one half of the total patients. 3) The duration of infertility between 1 and 4 years comprised about three quarters of the total patients, and the mean duration was 3.8 years. 4) The most common medical history in primary infertility was tuberculous disease, and that in secondary infertility was history of previous laparotomy. 5) About two thirds of antecedent pregnancies were abortion. 6) The major etiologic factor of infertility were male factor in 12.3%, tubal factor in 38.8%, ovulatory failure in 25.4%, uterine factor in 8.8%, cervical factor in 5.2%, peritoneal factor in 9.5%, and no demonstrable cause in 11.3%. 7) The types of male factor were azoospermia in 61.6%, oligospermia in 25.8%, low motility in 11.6%, and other abnormality in 1.0%. 8) The types of ovulatory failure were ovarian failure in 7.4%, hypothalamo-pituitary failure in 8.1 %, hypothalamo-pituitary dysfunction (including Polycystic ovarian syndrome) in 30.2%, and hyperprolactinemia in 22.4%. 9) The types of uterine factor were endometrial tuberculosis in 27.5%, uterine synechia in 33.8%, uterine anomaly in 19.7%, myoma and polyp in 9.1 %, and luteal phase defect in 9.9%. 10) The types of peritoneal factor were pelvic adhesion in 80.9% and endometriosis in 19.6%. 11) Surgeries were done in 408 patients, and they were salpingolysis, lysis of extraadnexal adhesion, salpingostomy, fimbrioplasty, ovarian wedge resection for polycystic ovarian disease, tubo-tubal anastomosis, and tubo-uterine implantation in orders. 12) 243 pregnancies were achieved during the infertility work-up, of which livebirth was 46.5%, ectopic pregnancy was 7.4%, spontaneous abortion was 7.8%, and on-going pregnancy or lost to follow-up was 36.2%. 13) Pregnancy rates in various factors were male factor in 18.7%, ovulatory factor in 31.7%, tubal factor in 24.2%, uterine factor in 34.6%, cervical factor in 19.0%, peritoneal factor in 29.0%, combined factors in 10.5%, and unexplained infertility in 37.1%. Pregnancy rate in whole patients was 25.2%.